Skip to main content
Caplight Logo









Foreseen Biotechnology

Foreseen Biotechnology

Private
TaipeiHealthcare & Life Scienceshttps://foreseen.bio

Company Overview

Foreseen Biotechnology operates in Healthcare & Life Sciences and is based in Taipei. It was founded in 2021.

Foreseen Biotechnology is a biotechnology company that develops a high-throughput integrated translational proteomics platform and AI-based analytics to discover novel therapeutic targets for cancer, inflammatory, autoimmune, and neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Foreseen Biotechnology Comparables

Compare Foreseen Biotechnology with similar companies based on industry and business-model similarity.

Foreseen Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Protai
85%
Sapient
76%
Recursion Pharmaceuticals
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Foreseen Biotechnology Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Foreseen Biotechnology. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Foreseen Biotechnology Investors

Notable investors and investment history

Foreseen Biotechnology investors
InvestorRounds
Nest.BioAccelerator
HongShan Capital Group (HSG)Early Funding

Foreseen Biotechnology Filings

Explore SEC and related filing metadata, where available.

Foreseen Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Foreseen Biotechnology's valuation, stock price, and market status.

Is Foreseen Biotechnology a public or private company?

Foreseen Biotechnology is a private company.

What is the current stock price of Foreseen Biotechnology?

Foreseen Biotechnology is a private company, so its shares have no public market price. Caplight tracks Foreseen Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Foreseen Biotechnology worth (valuation)?

Valuation information for Foreseen Biotechnology is not publicly available.

Can I buy Foreseen Biotechnology stock?

Foreseen Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Foreseen Biotechnology's last funding round?

Funding round information for Foreseen Biotechnology is not publicly available.

Who are the main investors in Foreseen Biotechnology?

Key investors in Foreseen Biotechnology include Nest.Bio, HongShan Capital Group (HSG).

Will Foreseen Biotechnology IPO soon?

No public IPO plans have been announced for Foreseen Biotechnology.

How can I track Foreseen Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades in Foreseen Biotechnology's shares on secondary markets.

Firmographic Details

HeadquartersTaipei
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?